Klapdor, R.; Wang, S.; Morgan, M.A.; Zimmermann, K.; Hachenberg, J.; Büning, H.; Dörk, T.; Hillemanns, P.; Schambach, A.
NK Cell-Mediated Eradication of Ovarian Cancer Cells with a Novel Chimeric Antigen Receptor Directed against CD44. Biomedicines 2021, 9, 1339.
https://doi.org/10.3390/biomedicines9101339
AMA Style
Klapdor R, Wang S, Morgan MA, Zimmermann K, Hachenberg J, Büning H, Dörk T, Hillemanns P, Schambach A.
NK Cell-Mediated Eradication of Ovarian Cancer Cells with a Novel Chimeric Antigen Receptor Directed against CD44. Biomedicines. 2021; 9(10):1339.
https://doi.org/10.3390/biomedicines9101339
Chicago/Turabian Style
Klapdor, Rüdiger, Shuo Wang, Michael A. Morgan, Katharina Zimmermann, Jens Hachenberg, Hildegard Büning, Thilo Dörk, Peter Hillemanns, and Axel Schambach.
2021. "NK Cell-Mediated Eradication of Ovarian Cancer Cells with a Novel Chimeric Antigen Receptor Directed against CD44" Biomedicines 9, no. 10: 1339.
https://doi.org/10.3390/biomedicines9101339
APA Style
Klapdor, R., Wang, S., Morgan, M. A., Zimmermann, K., Hachenberg, J., Büning, H., Dörk, T., Hillemanns, P., & Schambach, A.
(2021). NK Cell-Mediated Eradication of Ovarian Cancer Cells with a Novel Chimeric Antigen Receptor Directed against CD44. Biomedicines, 9(10), 1339.
https://doi.org/10.3390/biomedicines9101339